Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New approaches to mucosal immunization.

L Cárdenas-Freytag1, E Cheng, A Mirza

  • 1Tulane University School of Medicine, Department of Microbiology and Immunology, New Orleans, Louisiana 70112-2699, USA.

Advances in Experimental Medicine and Biology
|February 5, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unveiling the social and environmental benefits of electric vehicles: A case study of Shanghai.

Journal of environmental management·2025
Same author

Wireless Flexible Actuator Photoelectric Synergistically Driven for Environment Adaptability Crawling Robots.

ACS applied materials & interfaces·2025
Same author

Novel technique and outcomes of umbilical reconstruction during cytoreductive surgery; a multi-centre study.

Techniques in coloproctology·2025
Same author

Canadian Surgery Forum: Abstracts of presentations to the Annual Meetings of the Canadian Association of Bariatric Physicians and Surgeons, Canadian Association of General Surgeons, Canadian Association of Thoracic Surgeons, Canadian Hepato-Pancreato-Biliary Association, Canadian Society of Surgical Oncology, Canadian Society of Colon and Rectal Surgeons, Vancouver, BC, Sept. 17-21, 2013.

Canadian journal of surgery. Journal canadien de chirurgie·2025
Same author

A supported primary health pathway for mild traumatic brain injury quality improvement report.

Journal of primary health care·2024
Same author

Laser patterned graphene pressure sensor with adjustable sensitivity in an ultrawide response range.

Nanotechnology·2024
Same journal

Peptidomics in the Spotlight: Advanced Sample Treatment Techniques and Analytical Insights.

Advances in experimental medicine and biology·2026
Same journal

Methods for the Investigation of Protein-Ligands Interactions.

Advances in experimental medicine and biology·2026
Same journal

Sample Preparation Strategies for Microbial Cell Surface Proteomics: Integrating Shaving and Shotgun Approaches.

Advances in experimental medicine and biology·2026
Same journal

Proteomic Sample Preparation for the Petroleum Industry: A Biocorrosion Case Study.

Advances in experimental medicine and biology·2026
Same journal

Proteomic and Functional Comparison of Extracellular Vesicles from Wild-Type and Lyn-Deficient Stromal Cells.

Advances in experimental medicine and biology·2026
Same journal

Proteomic Analysis of Histone Sequence Variants and Post-translationally Modified Forms.

Advances in experimental medicine and biology·2026
See all related articles

Mucosal vaccines offer a promising strategy to combat infectious diseases, especially in underdeveloped countries. This review highlights LT(R192G), a novel mucosal adjuvant derived from E. coli, demonstrating its safety and efficacy for next-generation vaccines.

Area of Science:

  • Vaccinology
  • Immunology
  • Microbiology

Background:

  • Infectious diseases cause over 17 million deaths annually, primarily in underdeveloped nations, often from preventable diseases.
  • Pathogen entry via mucosal surfaces necessitates the development of effective mucosal vaccines.
  • Current strategies include attenuated microorganisms, lipid carriers, transgenic plants, and bacterial toxin-derived adjuvants.

Purpose of the Study:

  • To review recent advances in mucosal immunization strategies.
  • To emphasize the potential of LT(R192G), a genetically detoxified mucosal adjuvant, for developing new vaccines.

Main Methods:

  • Review of current literature on mucosal immunization techniques.
  • Focus on the development and evaluation of LT(R192G) as a mucosal adjuvant.

Related Experiment Videos

  • Assessment of safety, immunogenicity, and efficacy data for LT(R192G).

    • Main Results:

    • LT(R192G), derived from enterotoxigenic E. coli heat-labile toxin, is a promising mucosal adjuvant.
    • Evidence supports the safety, immunogenicity, and efficacy of LT(R192G).

    Conclusions:

    • LT(R192G) represents a significant advancement in mucosal adjuvant technology.
    • This adjuvant holds potential for the development of a new generation of effective mucosal vaccines against infectious diseases.